Results of Annual General Meeting

24th August 2021

Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces that all resolutions proposed at its Annual General Meeting held today were duly passed.

Download News

Back to all News